Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Nelson

Showing results (431-440 of 442) with videos related to

Pageof 45
Sort By:
Lancet (London, England)|February 23, 2020
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trialSarah Fidler, Wolfgang Stöhr, Matt Pace, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational studyCristina Mussini, Patrizio Pezzotti, José M Miró, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
HIV Medicine|August 30, 2016
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
HIV Medicine|August 20, 2011
British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011Mark Nelson, David Dockrell, Simon Edwards, et al.
HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.
HIV Medicine|December 17, 2013
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.), Ian Williams, Duncan Churchill, et al.
JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.
AIDS Patient Care and Stds|August 23, 2007
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretroviralsJacques Reynes, Keikawus Arastéh, Bonaventura Clotet, et al.
Pageof 45

Showing results (431-440 of 442) with videos related to

Sort By:
Pageof 45
Lancet (London, England)|February 23, 2020
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trialSarah Fidler, Wolfgang Stöhr, Matt Pace, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational studyCristina Mussini, Patrizio Pezzotti, José M Miró, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
HIV Medicine|August 30, 2016
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
HIV Medicine|August 20, 2011
British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011Mark Nelson, David Dockrell, Simon Edwards, et al.
HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.
HIV Medicine|December 17, 2013
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.), Ian Williams, Duncan Churchill, et al.
JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.
AIDS Patient Care and Stds|August 23, 2007
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretroviralsJacques Reynes, Keikawus Arastéh, Bonaventura Clotet, et al.
Pageof 45